Clinical Hours: Mon-Fri, 8AM - 3PM(905) 493-5700
1885 Glenanna Road, Suite 220, Pickering, ON, L1V 6R6
Seborrheic keratoses and moles can look nearly identical to the naked eye. What separates them, why melanoma sometimes hides among them, and how each one is assessed and removed.
A seborrheic keratosis is a benign overgrowth of keratinocytes, the structural cells that make up the outer layer of the skin. A mole, known clinically as a melanocytic naevus, is a benign overgrowth of melanocytes, the pigment-producing cells that sit at the base of that same layer. Two entirely different cell populations are involved, and yet both commonly present as a small brown bump. That overlap is the reason these two lesions are confused more often than any other pair in general dermatology.
A seborrheic keratosis arises from keratinocytes that have acquired activating somatic mutations, most often in the FGFR3 and PIK3CA genes. These mutations are present even in early flat lesions and become more frequent with advancing age and at particular body sites [1]. The result is a localized, benign thickening of the epidermis. Malignant transformation is not a recognized outcome, which is why a confidently diagnosed seborrheic keratosis requires no treatment at all.
Moles form when melanocytes cluster into nests rather than distributing evenly along the basement membrane. Most appear during childhood and adolescence, and the total number a person carries is largely determined by genetic background and cumulative sun exposure in early life. The distinction between the two lesion types matters clinically because melanocytic proliferations carry a small but genuine capacity for malignant change, whereas keratinocytic ones do not.
A histopathological review of seborrheic keratoses documented considerable variation in subtype, with acanthotic and hyperkeratotic patterns predominating, and it confirmed that pigmentation is a frequent finding rather than an unusual one [2]. That pigmentation is precisely what makes a keratinocytic lesion resemble a melanocytic one to the unaided eye.
Colour is the least reliable discriminator of the two. Seborrheic keratoses range from pale tan through to deep brown and near black, and moles occupy the same range. Both favour the trunk, face, and neck. Both may be raised above the skin surface. Both can itch, catch on clothing or jewellery, and bleed after minor trauma. None of these features points to one diagnosis over the other.
Timing offers a partial clue but not a dependable one. Seborrheic keratoses typically begin to appear after the fourth decade and accumulate steadily thereafter, whereas most moles are established by early adulthood. A brown lesion that was absent five years ago is therefore more likely to be a seborrheic keratosis on statistical grounds alone. That same history, however, describes a substantial proportion of melanomas, which is why chronology is never used on its own to close a diagnosis.
Stuck-on rather than grown-in. The single most useful clinical descriptor is the impression that the lesion has been placed onto the skin rather than emerging from it, with a sharply demarcated border that stops abruptly against normal skin. The surface is typically waxy, dull, or warty in texture, and a greasy scale can often be lifted at the edge. Plugged follicular openings give many lesions a pitted or pockmarked appearance, and lesions frequently occur in numbers rather than singly.
A common mole is usually smaller, smoother, and more symmetric. Colour tends to be uniform across the lesion, the border blends gradually into surrounding skin, and the outline is round or oval. Most importantly, the moles belonging to any one individual tend to resemble one another, forming a recognizable personal pattern. Mole count is also the strongest single phenotypic predictor of melanoma risk, with risk rising progressively as the number of common and atypical naevi increases [3].
Because individual features overlap so heavily, the more informative question is not what a lesion looks like in isolation but whether it fits the pattern set by its neighbours. The ugly duckling sign describes exactly this principle: a lesion that stands out from the others on the same patient warrants attention regardless of whether it satisfies any individual morphological checklist [4].
Instrument-assisted examination resolves most of the remaining uncertainty. Dermoscopy uses polarized light and magnification to reveal subsurface structures that are invisible to clinical inspection. A morphological study of pigmented seborrheic keratoses established the characteristic findings: milia-like cysts, comedo-like openings, fissures and ridges producing a brain-like surface, sharp demarcation, and a moth-eaten border [5]. Melanocytic lesions instead display pigment networks, globules, and streaks. A meta-analysis of studies conducted in clinical settings found dermoscopy substantially more accurate than naked-eye examination for the diagnosis of primary melanoma [6].
The clinical stakes of this comparison are set by a third possibility. In a review of 9,204 specimens submitted with a clinical diagnosis that included seborrheic keratosis, melanoma was identified in 61 cases, or 0.66 percent [7]. That proportion is small in relative terms and considerable in absolute terms, given how frequently seborrheic keratoses are diagnosed. Pigmented basal cell carcinoma can produce the same visual impression.
A related misconception concerns where melanoma comes from. A meta-analysis of naevus-associated melanoma found that only a minority of melanomas arise within a pre-existing mole, while the majority develop on skin that previously appeared normal [8]. Surveillance directed exclusively at existing moles therefore misses most disease. A genuinely new lesion deserves the same scrutiny as a changing old one.
Features that warrant assessment rather than reassurance: a lesion that has changed in size, shape, colour, or texture; growth that is asymmetric rather than uniform; bleeding or crusting in the absence of trauma; persistent itch localized to a single lesion; a pigmented lesion appearing for the first time after the age of 40; and any lesion that does not resemble its neighbours. The presence of one of these does not establish malignancy, but it does establish the need for examination.
When clinical and dermoscopic assessment together cannot exclude malignancy, a skin biopsy supplies the answer. Histopathological examination separates keratinocytic from melanocytic proliferation definitively, and no degree of surface inspection substitutes for it in a genuinely uncertain case.
No treatment is required for a seborrheic keratosis that has been confidently diagnosed and causes no symptoms. Removal is undertaken when a lesion is repeatedly irritated by clothing or straps, bleeds, becomes inflamed, or is cosmetically unwelcome on the face and neck. The decision is therefore driven by symptoms and preference rather than by risk.
Cryosurgery with liquid nitrogen and curettage are the two established office procedures. A comparative study of the two reported better cosmetic outcomes and higher patient satisfaction with curettage, although both cleared the lesions effectively [9]. Electrosurgery is commonly paired with curettage to control bleeding at the base. A topical hydrogen peroxide solution at 40 percent concentration has also been evaluated in two identical randomized, double-blind, placebo-controlled phase 3 trials, which demonstrated clearance superior to vehicle [10].
Selection among these options depends on lesion thickness, anatomical site, the number of lesions being treated, and skin tone. Cryosurgery carries a meaningful risk of persistent hypopigmentation in darker skin, so technique is adjusted accordingly rather than applied uniformly.
Management of a mole depends entirely on whether malignancy has been excluded. Stable, typical moles require no intervention beyond periodic observation. Lesions with equivocal features are either followed with sequential dermoscopic imaging, so that change over defined intervals can be measured rather than recalled, or removed outright for histopathological examination.
A rule that admits no exceptions: a pigmented lesion is never destroyed by cryosurgery, cautery, or laser before its nature is known. Destructive methods leave no tissue for the laboratory, and a melanoma treated in that way recurs later with its true depth and stage obscured. When mole removal is undertaken, whether for diagnostic or cosmetic reasons, the lesion is shaved or excised intact and submitted for examination. This is the principal practical reason that the two diagnoses must be separated before any instrument is applied.
Self-examination remains valuable provided its purpose is understood correctly. The objective is not to arrive at a diagnosis but to identify the lesions that merit professional assessment. Photographing a lesion of concern alongside a fixed reference point makes genuine change far easier to detect than memory allows. Patients with numerous moles, a personal or family history of melanoma, or a history of significant sun exposure benefit from scheduled examination rather than symptom-driven visits.
The conclusion is straightforward. Seborrheic keratoses and moles are biologically unrelated lesions that happen to share an appearance, and neither is dangerous in itself. What matters is that the distinction is drawn by someone equipped to draw it, and that no pigmented lesion is destroyed before that has happened. At the Centre for Medical and Surgical Dermatology, pigmented lesions are assessed by Dr. Maksym Breslavets using dermoscopy, with biopsy reserved for those that examination alone cannot resolve. To have a lesion evaluated, request a consultation.
This article is intended for educational purposes and does not replace professional medical advice. Please consult your dermatologist for personalized recommendations.
Your feedback helps us improve our news and clinical insights
From medical dermatology to surgical procedures, our clinic provides comprehensive care for all skin, hair, and nail conditions.